Back to overview
DRKS00031228

Snap Shot Audit Early Onset Colorectal Cancer - Are we doing enough or can we do more?

Data source: WHO (Imported from 29.08.2024)
Changed: Aug 23, 2024, 1:00 AM
Disease category:

Health conditions (Data source: WHO)


C18
C19
C20;Malignant neoplasm of colon;Malignant neoplasm of rectosigmoid junction;Malignant neoplasm of rectum

Interventions (Data source: WHO)

Group 1: Patients aged <50 at the time of diagnosis of the colorectal carcinoma during the 6 months lasting observation phase
Group 2: Patients aged >50 at the time of diagnosis of the colorectal carcinoma during the 6 months lasting observation phase

Inclusion/Exclusion Criteria (Data source: WHO)

Gender: All
Maximum age: None
Minimum age: 18 Years
Inclusion criteria: - new diagnosed colorectal carcinoma which qualifies for oncological therapy (palliative therapies included)
- Patients who have consented to the further use of their clinical data for research (general consent granted)
Exclusion criteria: - the colorectal carcinoma has not been confirmed
- the colorectal carcinoma was not defined as a primary carcinoma (e.g. colorectal metastasis of another underlying tumor disease)
- Missing general consent

Further information on the trial in WHO primary registry

http://drks.de/search/en/trial/DRKS00031228

Further information on the trial from WHO database (ICTRP)

https://trialsearch.who.int/Trial2.aspx?TrialID=DRKS00031228
Further information on trial

Date trial registered

Apr 19, 2023

Incorporation of the first participant

Jan 17, 2023

Recruitment status

Complete

Academic title (Data source: WHO)

Snap Shot Audit Early Onset Colorectal Cancer - Are we doing enough or can we do more? - EOCC

Type of trial (Data source: WHO)

observational

Design of the trial (Data source: WHO)

Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: diagnostic

Primary end point (Data source: WHO)

Modality of Diagnosis, Time to Diagnosis

Secundary end point (Data source: WHO)

- Evaluation of surgical techniques (open vs. minimal-invasive, CME, TME, extend of lymph node resection) in younger patients with colorectal cancer
-Evaluation of systemic therapies (neoadjuvant/adjuvant Chemotherapy, Radiation, total neoadjuvant therapy or immune therapy) in younger patients with colorectal carcinomas

Contact information (Data source: WHO)

Clarunis ? Universit?res Bauchzentrum Basel

Trial results (Data source: WHO)

Results summary

no information available yet

Link to the results in the primary register

http://drks.de/search/en/trial/DRKS00031228#studyResults

Information on the availability of individual participant data

No

Trial sites

Countries (Data source: WHO)

Switzerland

Contact for further information on the trial

Contact for general information (Data source: WHO)

Stephanie
Taha
Kleinriehenstrasse 30
Clarunis Universit?res Bauchzentrum Basel
0617777581
stephanie.taha@clarunis.ch

Contact for scientific information (Data source: WHO)

Stephanie
Taha
Kleinriehenstrasse 30
Clarunis Universit?res Bauchzentrum Basel
0617777581
stephanie.taha@clarunis.ch
Back to overview